The CORESTA Board

Role

The role of the Board is to define the strategic vision for the Association, provide policy guidance, set scientific direction for the Scientific Commission and to review its progress and output. The Board reviews and validates all documents and presentations produced and published under CORESTA’s name.

The Board typically meets twice a year, and holds specific meetings prior to and after the vote by the General Assembly.

Powers

The Board has full powers to act on behalf of the Association on all matters that do not specifically require the approval of a General Assembly.

The President is in charge of the execution of the decisions made by the Board and ensures, with the support of the General Secretariat, the proper functioning of the Association, which he represents with respect to all jurisdictions and acts of civil life.

Composition

The CORESTA Board comprises of 12 to 14 member-organisations. Ten are elected by the General Assembly from among the members of the Association, for a four-year tenure. Two to four other Members are co-opted by the elected Members, for a two-year tenure. Half of the elected Board Members and all co-opted ones are renewed every two years.

The members elected at the Board are requested to delegate as Administrators persons in active service within the Organisations who are well acquainted with the fields of activity of CORESTA and high-ranking, and therefore able to take an active part in Board activities.

The Board's Executive Committee consists of a President and a Vice-President, elected from among the administrators by secret ballot, for a two-year term, renewable once, and defined as intuitu personae.

Members 2016-2018

The Board Member Organisations and their representatives for the 2016-2018 period are as follows:

President:            Mr Huub Vizée – delfort AG (Austria)
Vice-President:   Mrs Diane Raverdy-Lambert – SWM International Inc. (USA)

Member Represented by
Alliance One International, Inc.
(USA)
Dr Henri Papenfus
Consultant
Alternative Ingredients, Inc.
(USA)
Mr. Eduardo Berea
International Sales Manager
Borgwaldt KC GmbH
(Germany)
Dr Nils Rose
Managing Director
British American Tobacco
(UK)
Dr. Derek Mariner
Principal Scientist
China National Tobacco Corporation
(China)
Dr Xianping Xie
President of Zhengzhou Tobacco Research Institute
delfort AG
(Austria)
Mr Huub Vizée (Board President)
Head of Regulatory Affairs
Imperial Tobacco Ltd
(UK)
Dr Joseph Thompson
Director Product Science
Japan Tobacco Inc.
(Japan)
Dr Keigo Miura
Vice President, Scientific and Regulatory Affairs Division
KT&G Corporation
(South Korea)
Dr Hyo-Keun Kim
Director of Analysis Research Center
Reynolds American Inc. Services Co.
(USA)
Dr Michael Ogden
Vice President, Scientific & Regulatory Affairs
Swedish Match AB
(Sweden)
Dr Johan Lindholm
Director R&D, Analytical & Product Science
SWM International Inc.
(USA)
Mrs Diane Raverdy-Lambert (Board Vice-President)
Chief Scientist & Director Regulatory Affairs
Universal Leaf Tobacco Company
(USA)
Mr Mauri Winegardner
Vice President
University of Kentucky
(USA)
Ms Anne Jack
Research Specialist, Kentucky Tobacco R&D Center